interleukin 1beta (193-195) has been researched along with adenosine in 1 studies
Studies (interleukin 1beta (193-195)) | Trials (interleukin 1beta (193-195)) | Recent Studies (post-2010) (interleukin 1beta (193-195)) | Studies (adenosine) | Trials (adenosine) | Recent Studies (post-2010) (adenosine) |
---|---|---|---|---|---|
18 | 0 | 2 | 32,536 | 1,075 | 8,930 |
Protein | Taxonomy | interleukin 1beta (193-195) (IC50) | adenosine (IC50) |
---|---|---|---|
high affinity choline transporter 1 isoform a | Homo sapiens (human) | 0.3851 | |
Sodium/nucleoside cotransporter 1 | Homo sapiens (human) | 5.5 | |
Sodium/nucleoside cotransporter 2 | Homo sapiens (human) | 5.5 | |
Adenosine receptor A3 | Homo sapiens (human) | 0.0011 | |
Adenosine receptor A1 | Homo sapiens (human) | 0.0023 | |
Equilibrative nucleoside transporter 1 | Homo sapiens (human) | 63 | |
Solute carrier family 28 member 3 | Homo sapiens (human) | 3.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
An, XM; Leung, WK; Lv, MM; Ren, TH; Seto, WK | 1 |
1 other study(ies) available for interleukin 1beta (193-195) and adenosine
Article | Year |
---|---|
Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down-regulating the nuclear factor-kappa B signaling.
Topics: Adenosine; Colitis, Ulcerative; Colon; Cytokines; Down-Regulation; Humans; Inflammation; Interleukin-1beta; Intestinal Mucosa; NF-kappa B; Peptide Fragments; Purinergic P1 Receptor Agonists; Receptor, Adenosine A3; Signal Transduction; Tumor Necrosis Factor-alpha; Up-Regulation | 2020 |